Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-819-0 | CAS number: 7328-91-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 (oral, rat): 1020 mg/kg bw
LD50 (dermal, rat): >1000 < 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- according to BASF-internal standard
- GLP compliance:
- no
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- A standardized animal laboratory diet was used.
Fasting period: 15 - 20 h before administration. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The test concentrations used were 6.81, 10 and 14.7% (G/V); aqueous solution.
Application volume: 10 ml/kg. - Doses:
- 681, 1000, and 1470 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 020 mg/kg bw
- Mortality:
- Male animals: 681 mg/kg: 1/5 after 14 days; 1000 mg/kg: 3/5 after 14 days; 1470 mg/kg: 5/5 after 14 days
Female animals: 681 and 1000 mg/kg: no deaths after 14 days; 1470 mg/kg: 5/5 after 14 days - Clinical signs:
- Dyspnea, gasping, apathy, abnormal position, staggering, atony, pain and cornea reflexes missing, spastic gait, urine intense yellow-coloured, ruffled fur, exophthalmos, blood in the nose, breathlessness, poor general state
- Body weight:
- Mean body weight for male animals: 260 g at study start, 318 g after 13 days
Mean body weight for female animals: 187 g at study start, 253 g after 13 days - Gross pathology:
- Animals that died: heart: acute dilatation (right), acute congestive hyperemia; lung: acute flatulence (middle-graded); liver: peripheral lobular pattern; stomach: dilated, atonic, glandular stomach diffusely reddened (severe irritative gastritis); intestine: diffuse reddening of the mucosa, atonic, diarrheic content (enteritis).
Sacrificed animals: nothing abnormal detected. - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 acute oral was 1020 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 020 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- according to BASF-internal standard
- GLP compliance:
- no
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Mean body weights: males 191 g, females 164 g
A standardized animal laboratory diet was offered. - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- Application area: 25 cm2
Application site: back - Duration of exposure:
- 24 h
- Doses:
- 1000 and 2000 mg/kg
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 - < 2 000 mg/kg bw
- Mortality:
- 1000 mg/kg: no deaths after 14 days; 2000 mgkg: all animals died within 48 hours
- Clinical signs:
- Toxic symptoms: intermittently breathing, apathy, staggering, spastic gait, tonic convulsions, trembling
Local skin findings: after 24 hours necrosis was observed, which was not reversible within 14 days - Gross pathology:
- Animals that died: heart: acute dilatation (right), acute congestive hyperemia; kidneys: remarkable pale
Sacrificed animals: nothing abnormal detected - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 dermal for rats was >1000 < 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
Additional information
Acute oral toxicity
In an acute oral toxicity study, groups of fasted Sprague-Dawley rats (5/sex) were given a single oral dose of the test substance at doses of 681, 1000 and 1470 mg/kg). Animals were observed for 14 days (BASF AG, 1979). All animals died in the highest dosing group during the first day. 3 male animals died at 1000 mg/kg after 2 days. At the lowest dosing group one male died after 2 days.
Clinical signs are dyspnea, gasping, apathy, abnormal position, staggering, atony, pain and cornea reflexes missing, spastic gait, urine intense yellow-coloured, ruffled fur, exophthalmos, blood in the nose, breathlessness, poor general state. Animals that died: heart: acute dilatation (right), acute congestive hyperemia; lung: acute flatulence (middle-graded); liver: peripheral lobular pattern; stomach: dilated, atonic, glandular stomach diffusely reddened (severe irritative gastritis); intestine: diffuse reddening of the mucosa, atonic, diarrheic content (enteritis). Nothing abnormal was detected for the sacrificed animals.
Based on the results of this study an LD50 of 1020 mg/kg was determined.
Acute dermal toxicity
In an acute dermal toxicity study, groups of Sprague-Dawley rats (3/sex) were dermally exposed to the unchanged test substance at concentrations of 1000 and 2000 mg/kg bw for 24 hours (BASF AG, 1979). Animals were then observed for 14 days. No mortality was observed at the 1000 mg/kg. All animals at 2000 mg/kg died within 48 hours. Clinical signs were intermittently breathing, apathy, staggering, spastic gait, tonic convulsions, trembling. Local skin findings after 24 hours necrosis were observed, which were not reversible within 14 days. Animals that died: heart: acute dilatation (right), acute congestive hyperemia; kidneys: remarkable pale. Nothing abnormal detected for sacrificed animals. Based on these findings an LD50 of > 1000 < 2000 mg/kg bw was determined.
Justification for classification or non-classification
Based on the results on acute toxicity testing, the test item is classified and labelled as harmful after single ingestion (cat. 4, H302) and harmful after single skin contact (cat. 4, H312) according to Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.